Clinical Trials Browser

Phase 1 × Lymphoma, Follicular × Lomustine × Clear all

NCT01989052 2016-08-04

Ph 1/2 CTO With Lomustine for Bevacizumab-Naive Recurrent Glioma

Phase 1 Terminated

Glioma, Lymphoma, Follicular